| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |